Download the complimentary Guide to Successful Copay Programs that delivers actionable insights to...
Author - simom
Boost returns from social strategies with new channels and...
Emerging channels offer new ways to reach key targets and improve campaign ROI.
A biotech CEO’s favorite ‘F’ word
At SFA Therapeutics, patients are the “focus” of Ira Spector’s approach to changing the...
With Twitter in flux, pharma is turning to alternative social...
Elon Musk’s takeover of Twitter has upended the ways pharma companies communicate with doctors...
Gilead’s commercial chief on why 2023 will be a ‘coming...
With a rapidly expanding oncology pipeline and a new approval in HIV, Johanna Mercier discusses...
Woman of the Week: Dr. Lauren Lazar
As Calcium’s medical director, Lazar is leveraging next-generation innovation to create strategic...
Economic crisis? J&J execs say that won’t stop them from...
The pharma giant's CEO Joaquin Duato and CFO Joseph Wolk showed that they're optimistic...
Report reveals murky picture of clinical trial diversity gains
Data discrepancies between study phases and indications could provide clues about why some trials...
AstraZeneca’s newest asthma launch fills a gap as generics...
A longtime leader in the respiratory space, AstraZeneca has hammered another stake in the ground...
OxSonics trial produces positive SonoTran data
During the research SonoTran is being evaluated in patients with metastatic colorectal cancer